login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Immune Pharmaceuticals Inc. (IMNP) Stock News
USA
- NASDAQ:IMNP -
0.064
-0.1 (-61.21%)
Last: 9/10/2018, 5:44:59 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IMNP Latest News, Press Relases and Analysis
All
Press Releases
8 years ago - By: Active-Investors
- Mentions:
JNJ
Wired News – Johnson & Johnson to Pay Compensatory Damages over Claims Linking Cancer to Asbestos in Talc
8 years ago - By: dailystocktracker.com
- Mentions:
ZGNX
SHPG
ABBV
Technical Snapshots for These Drug Makers Stocks -- Immune Pharma, Zogenix, Shire, and AbbVie
7 years ago - By: Benzinga
- Mentions:
ABMD
ALKS
ALXN
AMGN
...
Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold
7 years ago - By: Benzinga
- Mentions:
AGEN
CLDX
IBB
OPNT
...
Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap
8 years ago - By: Analyst Ratings
Maxim Group Thinks Immune Pharmaceuticals’ Stock is Going to Recover
8 years ago - By: Immune Pharmaceuticals Inc.
Immune Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides a Corporate Update
8 years ago - By: Immune Pharmaceuticals Inc.
Immune Pharmaceuticals Inc. Announces Closing of $18,000,000 Public Offering of Convertible Preferred Stock and Warrants
Please enable JavaScript to continue using this application.